{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T17:10:52Z","timestamp":1784999452715,"version":"3.55.0"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This review of omalizumab use in chronic spontaneous urticaria (CSU) in Auckland City Hospital's immunology department in 2023 showed that rates of baseline investigations were high but did not clearly improve CSU management. There were associations between raised C\u2010reactive protein and higher doses of omalizumab, and lower C\u2010reactive protein and CSU remission. Most patients had angioedema and atopy. Median symptom duration was 5\u2009years and the majority needed at least 1 year of omalizumab treatment. Fewer M\u0101ori\/Pasifika patients in this cohort may reflect barriers to accessing health care.<\/jats:p>","DOI":"10.1111\/imj.70354","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T09:57:14Z","timestamp":1772963834000},"page":"706-709","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Insights into omalizumab use in Auckland City Hospital's immunology 2023 chronic spontaneous urticaria cohort"],"prefix":"10.1111","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9198-5610","authenticated-orcid":false,"given":"Nathaniel","family":"Triffitt","sequence":"first","affiliation":[{"name":"Immunology Department Auckland City Hospital  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lindsay","sequence":"additional","affiliation":[{"name":"Immunology Department Auckland City Hospital  Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"e_1_2_4_2_1","unstructured":"Zuberbier T Aberer W Asero R Abdul Latiff AH Baker D Ballmer\u2010Weber Bet al2018;73:1393\u20131414."},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.15568"},{"key":"e_1_2_4_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13601-015-0082-7"},{"key":"e_1_2_4_5_1","unstructured":"Position Paper\u2010Chronic Spontaneous Urticaria (CSU) (Internet).ASCIA.2020.https:\/\/www.allergy.org.au\/images\/stories\/pospapers\/ASCIA_HP_Position_Paper_CSU_2020.pdf."},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-443-23947-2.00001-1"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-024-01173-5"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.06.014"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15350"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.07.047"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215372"},{"key":"e_1_2_4_12_1","unstructured":"Novartis NZ Ltd.Xolair data sheet 10 August 2017.https:\/\/medsafe.govt.nz\/profs\/Datasheet\/x\/Xolairinj.pdf"},{"key":"e_1_2_4_13_1","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1016\/j.jid.2025.06.739","article-title":"0727 geographic and demographic disparities in chronic spontaneous urticaria clinical trials","volume":"145","author":"Joshi A","year":"2025","journal-title":"J Invest Dermatol"},{"key":"e_1_2_4_14_1","unstructured":"Stats NZCensus: Final content report (Internet)2023."},{"key":"e_1_2_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15090"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2025.1688464"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70354","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.70354","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.70354","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:53:10Z","timestamp":1778086390000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.70354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.1111\/imj.70354"],"URL":"https:\/\/doi.org\/10.1111\/imj.70354","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"2025-06-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}